Spotlight Session | Live Case &
Late-Breaking Trials from TCT
November 9, 2024
9:00 AM ET
Welcome and Introduction
Ron Waksman, MD
LIVE CASE | MEDSTAR WASHINGTON HOSPITAL CENTER
9:05 AM ET
Live Case | Broadcasting From MedStar Washington Hospital Center | Washington, DC
Live Case Operators:
Itsik Ben-Dor, MD | MedStar Washington Hospital Center
Hayder Hashim, MD | MedStar Washington Hospital Center
Lowell Satler, MD | MedStar Washington Hospital Center
Live Case Moderator(s):
Maurice Buchbinder, MD | Foundation for Cardiovascular Medicine
Ron Waksman, MD | MedStar Washington Hospital Center
Live Case Panelist(s):
Giorgio Medranda, MD | NYU Langone Hospital – Long Island
Nadia Sutton, MD | Vanderbilt University Medical Center
LATE-BREAKING TRIALS | TCT
Moderator(s):
Ron Waksman, MD | MedStar Washington Hospital Center
Moderator [10:00 AM – 11:15 AM]:
David Cohen, MD | Cardiovascular Research Foundation
Panel Discussant(s):
Mirvat Alasnag, MD | King Fahd Armed Forces Hospital
Azeem Latib, MD | Montefiore Medical Center
Toby Rogers, MD, PhD | MedStar Washington Hospital Center
Bruce Rutkin, MD | Northwell Health
10:00 AM ET
Early TAVR: Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial
Speaker: Philippe Genereux, MD | Morristown Medical Center
10:15 AM ET
Panel Discussion
10:25 AM ET
TAVR UNLOAD: Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis
Speaker: Nicholas M. Van Mieghem, MD | Thoraxcenter, Erasmus University Medical Centre
10:40 AM ET
Panel Discussion
10:50 AM ET
ECLIPSE: A Large-Scale, Randomized Trial of Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation
Speaker: Ajay J. Kirtane, MD | Columbia University Irving Medical Center
11:05 AM ET
Panel Discussion
11:15 AM ET
TRISCEND II: Randomized Comparison of Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation
Speaker: Suzanne V. Arnold, MD | Saint Luke’s Mid America Heart Institute
11:30 AM ET
Panel Discussion
11:40 AM ET
One-Year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-Risk Patients with Severe AS: The ACURATE IDE Trial
Speaker: Michael Reardon, MD | Houston Methodist DeBakey Heart & Vascular Center
